Styrenic
Block Copolymers Market was
valued at USD 760 million and is expected to grow
at a CAGR of 21.3% from 2013 to 2019 to reach an estimated value of USD 2,937.3 million by 2019.
Browse the full report at http://www.transparencymarketresearch.com/styrenic-block-copolymers.html
Demand for SBCs in the medical industry is primarily driven by a
growing trend of replacing PVC products by SBCs, primarily due to health and
environmental issues related with PVC usage. However, volatility in raw
material prices has emerged as a critical challenge to SBC producers worldwide.
Increasing R&D in bio-based SBC plastics is expected to herald the most
promising opportunity in the market; bio-based SBCs along with being
environment friendly are also economically feasible against their synthetic
counterparts.
Styrene Ethylene Butylene Styrene (SEBS) is the most dominant SBC
product consumed by the medical and healthcare industry and accounted for over
68% of total medical SBC volumes in 2011. SEBS is primarily used for
manufacturing medical bags (including IV, CAPD and blood bags) and other
flexible materials in the medical industry. SEBS is also the fastest growing
type of SBC used in the medical sector.
No comments:
Post a Comment